Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trialRobert I. Haddad, Marshall R. Posner, Joseph I. Clark et al.|The Lancet Oncology|2013Cited by 748
A randomized phase II study of docetaxel with or without vandetanib in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN)Sewanti Limaye, Robert I. Haddad, Sarah Riley et al.|Oral Oncology|2013Cited by 59
The PARADIGM trial: A phase III study comparing sequential therapy (ST) to concurrent chemoradiotherapy (CRT) in locally advanced head and neck cancer (LANHC).Robert I. Haddad, Marshall R. Posner, Sarah Riley et al.|Journal of Clinical Oncology|2012Cited by 44